|
Sign In to gain access to subscriptions and/or personal tools.
|
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis
J de Seze
Department of Neurology, Hôpital R. Salengro, University of Lille, France, j-deseze{at}chru-lille.fr
C Lebrun
Department of Neurology, University of Nice, France
T Stojkovic
Department of Neurology, Hôpital R. Salengro, University of Lille, France
D Ferriby
Department of Neurology, Hôpital R. Salengro, University of Lille, France
M Chatel
Department of Neurology, University of Nice, France
P Vermersch
Department of Neurology, Hôpital R. Salengro, University of Lille, France
Devic's neuromyelitis optica (NMO) associates optic neuritis and myelopathy without other neurological signs. Many patients with NMO may be diagnosed as having multiple sclerosis (MS). However, there have been no previous studies comparing these two patho logies and it is still unclear if NMO is a separate entity or a subtype of MS. In the present study, we compared a series of NMO patients with a series of MS patients for whom optic neuritis or myelopathy was the presenting symptom, in order to determine the place of NMO in the spectrum of MS. We retrospectively studied 30 patients diagnosed with NMO and we compared these patients with 50 consecutive MS cases revealed by optic neuritis or acute myelopathy. MS patients were only included if a relapse occurred demonstrating time and space dissemination. We compared the two groups in terms of clinical presentatio n, laboratory findings (MRI and C SF) and clinical outcome. NMO patients were older and more frequently women than MS patients but the difference was not significant. C SF and MRI data were clearly different: oligoclonal bands (O C B) were found in 23% of NMO cases and 88% of MS (P B/0.001), abnormal brain MRI data were observed in 10% of NMO cases and 66% of MS (P B/0.001) and a large spinal cord lesion was observed in 67% of NMO cases and 7.4% of MS cases (P B/0.001). C linical outcome was evaluated as more severe in the NMO group (P B/0.001). O n the basis of clinical data, all NMO patients but three had dissemination in time and space. When we included MRI parameters, only two of the NMO patients met criteria for MS and one of the MS patients met criteria for NMO. O ur study demonstrates that NMO and MS should be considered as two different entities. The respective criteria for NMO and MS were able to distinguish these two patho logies but only when MRI data were applied. This finding could have implications for future therapeutic trials.
Key Words: comparative • Devic's neuromyelitis optica • multiple sclerosis • myelopathy
Multiple Sclerosis, Vol. 9, No. 5,
521-525 (2003)
DOI: 10.1191/1352458503ms947oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
P Cabre, A Gonzalez-Quevedo, M Bonnan, A Saiz, S Olindo, F Graus, D Smadja, H Merle, L Thomas, and J A Cabrera-Gomez
Relapsing neuromyelitis optica: long term history and clinical predictors of death
J. Neurol. Neurosurg. Psychiatry,
October 1, 2009;
80(10):
1162 - 1164.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al.
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Multiple Sclerosis,
November 1, 2008;
14(9):
1157 - 1174.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J-S Wu, M-N Zhang, W M Carroll, and A G Kermode
Characterisation of the spectrum of demyelinating disease in Western Australia
J. Neurol. Neurosurg. Psychiatry,
September 1, 2008;
79(9):
1022 - 1026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. de Seze, F. Blanc, L. Jeanjean, H. Zephir, P. Labauge, M. Bouyon, L. Ballonzoli, G. Castelnovo, M. Fleury, S. Defoort, et al.
Optical Coherence Tomography in Neuromyelitis Optica
Arch Neurol,
July 1, 2008;
65(7):
920 - 923.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. de Seze
Monophasic Acute, Recurrent, and Multiphasic Disseminated Encephalomyelitis and Multiple Sclerosis--Reply
Arch Neurol,
May 1, 2008;
65(5):
676 - 676.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Marignier, J. De Seze, S. Vukusic, F. Durand-Dubief, H. Zephir, P. Vermersch, P. Cabre, G. Cavillon, J. Honnorat, and C. Confavreux
NMO-IgG and Devic's neuromyelitis optica: a French experience
Multiple Sclerosis,
May 1, 2008;
14(4):
440 - 445.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. de Seze
Multiple Sclerosis and Recurrent Disseminated Encephalomyelitis Are Different Diseases--Reply
Arch Neurol,
May 1, 2008;
65(5):
674 - 675.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Blanc, H. Zephir, C. Lebrun, P. Labauge, G. Castelnovo, M. Fleury, F. Sellal, C. Tranchant, K. Dujardin, P. Vermersch, et al.
Cognitive Functions in Neuromyelitis Optica
Arch Neurol,
January 1, 2008;
65(1):
84 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Fukazawa and S Kikuchi
A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the 'attack-related severity' axis
Multiple Sclerosis,
March 1, 2007;
13(2):
199 - 207.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. M. Wingerchuk, V. A. Lennon, S. J. Pittock, C. F. Lucchinetti, and B. G. Weinshenker
Revised diagnostic criteria for neuromyelitis optica
Neurology,
May 23, 2006;
66(10):
1485 - 1489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rubiera, J. Rio, M. Tintore, C. Nos, A. Rovira, N. Tellez, and X. Montalban
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis
Neurology,
May 23, 2006;
66(10):
1568 - 1570.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y. K. Chan and D. T. L. Liu
Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome
Rheumatology,
January 1, 2006;
45(1):
120 - 121.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Y Poppe, Y. Lapierre, D. Melancon, D. Lowden, L. Wardell, L. M Fullerton, and A. Bar-Or
Neuromyelitis optica with hypothalamic involvement
Multiple Sclerosis,
October 1, 2005;
11(5):
617 - 621.
[Abstract]
[PDF]
|
|
|
|
|
